The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). Show more
http://www.fool.com/investing/general/2015/12/05/these-3-etfs-jumped-in-november.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/30/last-weeks-top-healthcare-etf.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/22/3-biotech-stocks-to-buy-in-december.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/01/the-top-3-biotech-etfs-on-the-market.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/05/31/improve-your-diversification-strategy-with-these-3.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/high-growth/2015/05/09/a-stock-market-bubble-in-biotech-stocks.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/beginning/2015/04/19/how-to-invest-money-in-biotech.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/etf/2015/03/31/these-3-etfs-are-crushing-the-market-in-2015.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/general/2015/03/23/3-biotech-stocks-to-buy-if-the-sector-crashes.aspx?source=eptadnlnk0000002
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.2 | 4.24757281553 | 98.88 | 103.52 | 97.96 | 7881642 | 100.73977706 | SP |
4 | 1 | 0.979623824451 | 102.08 | 103.52 | 95.43 | 6601450 | 99.87012734 | SP |
12 | 10.69 | 11.5705162896 | 92.39 | 103.52 | 90.28 | 7428488 | 97.9466672 | SP |
26 | 10.44 | 11.2694300518 | 92.64 | 103.52 | 81.14 | 8670426 | 92.99174179 | SP |
52 | 27.05 | 35.5780612916 | 76.03 | 103.52 | 63.8 | 9975431 | 87.0059884 | SP |
156 | -27.27 | -20.920598389 | 130.35 | 134.79 | 61.78 | 9941893 | 86.71416648 | SP |
260 | 20.3 | 24.5228316018 | 82.78 | 174.79 | 61.78 | 8283125 | 94.08996959 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.